Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania-Reference-Cited by-同舟云学术

Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania

Published:2020-07-22 Issue:1 Volume:20 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Bwire George M.,Mikomangwa Wigilya P.,Kilonzi Manase

Funder

Swedish International Development Cooperation Agency (Sida), Sweden

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-020-05253-7.pdf

Reference27 articles.

1. Patouillard E, Griffin J, Bhatt S, Ghani A, Cibulskis R. Global investment targets for malaria control and elimination between 2016 and 2030. BMJ Glob Health. 2017;2(2):e000176.

2. WHO. Global report on antimalarial drug efficacy and drug resistance: 2000–2010, vol. 115: Who; 2010.

3. Mohammed A, et al. Trends in chloroquine resistance marker , Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malar J. 2013;12(1):1.

4. NDEJEMBI M, et al. Therapeutic efficacy of Sulfadoxine-Pyrimethamine and prevalence of resistance markers in Tanzania Prior to revision of malaria treatment policy: Plasmodium falciparum Dihydrofolate Reductase and Dihydropteroate synthase mutations in monitoring in vivo re. Am J Trop Med Hyg. 2018;71(6):696–702.

5. Mubyazi GM, Gonzalez-Block MA. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malar J. 2005;4:1–13.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of piperaquine and its association with intermittent malaria preventive therapy outcomes during pregnancy;BMC Pharmacology and Toxicology;2024-07-08

2. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021;Malaria Journal;2024-04-03

3. Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Pregnancy: Low Coverage and High Prevalence of Plasmodium falciparum dhfr-dhps Quintuple Mutants as Major Challenges in Douala, an Urban Setting in Cameroon;Pathogens;2023-06-19

4. Molecular Determinants of Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum Isolates from Central Africa between 2016 and 2021: Wide Geographic Spread of Highly Mutated Pfdhfr and Pfdhps Alleles;Microbiology Spectrum;2022-10-26

5. The prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine among pregnant women at first antenatal clinic attendance and delivery in the forest-savannah area of Ghana;PLOS ONE;2022-08-08